Khosla Ventures Acquisition Co
Change company Symbol lookup
Select an option...
KVSA Khosla Ventures Acquisition Co
FPI Farmland Partners Inc
HNST Honest Company Inc
ONTF ON24 Inc
ATAI ATAI Life Sciences NV
FTS Fortis Inc
VLO Valero Energy Corp
BBLN+ Babylon Holdings Equity Warrants 21st Oct 2026 *W EXP 10/21/2026
NEGG Newegg Commerce Inc
LTRY Lottery.com Inc
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Company profile

Khosla Ventures Acquisition Co. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus its search on market opportunity with differentiated, proprietary technology. The Company has not commenced any operations and has not generated revenues.

Closing Price
$9.81
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.82
Day's Low
9.79
Volume
(Heavy Day)
Volume:
172,786

10-day average volume:
19,311
172,786

Pfizer agrees to buy Global Blood Therapeutics in deal valued at $5.4 billion: WSJ

6:37 am ET August 8, 2022 (MarketWatch)
Print

Pfizer Inc. (PFE) has reached an agreement to buy Global Blood Therapeutics Inc. [s :gbt] in a deal valued at $5.4 billion, the Wall Street Journal reported, citing people familiar with the matter. The news comes after the Journal reported Friday that the two were in advanced talks. Pfizer will pay $68.50- a share in cash for Global Blood Therapeutics, which has one of few approved treatments for sickle-cell disease. The companies are expected to announce the deal later Monday. Global Blood Therapeutics shares rose 1.8% in premarket trade Monday, and are up 118% in the year to date, while the S&P 500 has fallen 13%.

-Ciara Linnane

	

(END) Dow Jones Newswires

August 08, 2022 06:37 ET (10:37 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.